TRU-SENTIMENT · DeltaNeutral
ACAD Trading Analysis - 09/23/2026 01:41 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ACAD (Acadia Pharmaceuticals Inc.) at $25.02. True Sentiment Bullish, delta 40-60 call 99% / put 1%, call $501,400 vs put $4,250. RSI 19.0.
- Symbol
- ACAD
- Price
- $25.02
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- medium
- Published
- 2026-09-23 13:41:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis:Options flow sentiment: Bullish
Call vs Put dollar volume: Calls account for 99.2% of the total dollar volume.
Pure directional positioning suggests near-term expectations are bullish.
Key Statistics: ACAD
Fundamental Snapshot
Valuation
| P/E (Trailing) | 11.84 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 6.96 |
Profitability
| EPS (Trailing) | $2.23 |
| EPS (Forward) | N/A |
| ROE | 29.12% |
| Net Margin | 33.42% |
Financial Health
| Revenue (TTM) | $1.14B |
| Debt/Equity | 0.33 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ACAD include:
- ACADIA Pharmaceuticals announces FDA approval for a new treatment.
- The company reports strong quarterly earnings, beating analyst expectations.
- ACADIA Pharmaceuticals faces increased competition in the pharmaceutical industry.
These headlines may impact the stock's price action and sentiment. The FDA approval and strong earnings report could be positive catalysts, while increased competition could be a negative factor.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $1,138,643,000
- Trailing EPS: $2.23
- Trailing P/E: 11.84
- Price-to-Book: 6.96
- Debt-to-Equity: 0.33
- Return on Equity (ROE): 29.12%
- Gross Margin: 91.13%
- Operating Margin: 7.59%
- Profit Margin: 33.42%
The company's revenue and profit margins are strong, with a high gross margin and a relatively low debt-to-equity ratio. However, the trailing P/E ratio is around 11.84, which may indicate undervaluation or a lack of growth expectations.
Current Market Position:
Current price: $25.01
Recent price action: The stock has been trending downward, with a recent low of $24.93.
Key support and resistance levels:
| Level | Price |
|---|---|
| Support | $24.93 |
| Resistance | $27.81 |
Technical Analysis:
SMA trends:
- SMA 5: $26.51
- SMA 20: $27.81
- SMA 50: $27.62
RSI (14): 19.04, indicating oversold conditions.
MACD: -0.55, with a bearish signal.
Bollinger Bands: The stock is trading near the lower band, indicating potential oversold conditions.
True Sentiment Analysis:
Options flow sentiment: Bullish
Call vs Put dollar volume: Calls account for 99.2% of the total dollar volume.
Pure directional positioning suggests near-term expectations are bullish.
Key Price Levels:
| Level | Price |
|---|---|
| Support | $24.93 |
| Resistance | $27.81 |
25-Day Price Forecast:
Based on current trends and indicators, ACAD is projected for $23.50 to $26.50.
The projection is based on the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).
Defined Risk Strategy Recommendations:
Based on the price forecast, consider the following defined risk strategies:
- Bull Call Spread: Buy the $25.0 call and sell the $27.0 call.
- Bear Put Spread: Buy the $24.0 put and sell the $22.0 put.
- Iron Condor: Sell the $25.0 call, buy the $27.0 call, sell the $24.0 put, and buy the $22.0 put.
Risk Factors:
- Technical warning signs: The stock is oversold, but the trend is still bearish.
- Sentiment divergences: The options flow is bullish, but the technical indicators are bearish.
- Volatility and ATR considerations: The recent volatility has been high, with an ATR of 0.84.
Summary & Conviction Level:
Overall bias: Neutral
Conviction level: Medium
One-line trade idea: Consider defined risk strategies based on the price forecast.
View ACAD Options Chain